41 – 50 of 4955
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2025
- 
                        Mark
        Statin Therapy in Early Breast Cancer : The MASTER Trial; A Randomized Phase III, Placebo-Controlled Comparison of Standard (Neo)Adjuvant Therapy Plus Atorvastatin versus Standard (Neo)Adjuvant Therapy Plus Placebo
    
    - Contribution to journal › Article
 
- 
                        Mark
        Validation of data quality in the Swedish quality register of gynecologic cancer for cervical cancer and vulvar cancer—a Swedish gynecologic cancer group (Swe-GCG) study
    
    - Contribution to journal › Article
 
- 
                        Mark
        European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma : Summary of the 2025 Update
    
    - Contribution to journal › Debate/Note/Editorial
 
- 
                        Mark
        Implementation of standard of care CAR-T-cell treatment for patients with aggressive B-cell lymphoma and acute lymphoblastic leukemia in Sweden : LYMPHOMA
    
    - Contribution to journal › Letter
 
- 
                        Mark
        Interplay between AHR genotypes, lifestyle factors and adjuvant breast cancer treatments significantly impacts clinical outcome in a population-based cohort
    
    - Contribution to journal › Article
 
- 
                        Mark
        Prognostic Differences of Adjuvant Radiotherapy in Breast Cancer Cohorts Based on PRLR Genotypes, Expression, and Transcriptional Network Regulation
    
    - Contribution to journal › Article
 
- 
                        Mark
        Swedish national guidelines on urothelial carcinoma : 2024 update on advanced and metastatic disease
    
    - Contribution to journal › Article
 
- 
                        Mark
        Imatinib alternating with regorafenib compared to imatinib alone for the first-line treatment of advanced gastrointestinal stromal tumor : The AGITG ALT-GIST intergroup randomized phase II trial: Clinical Studies
    
    - Contribution to journal › Article
 
- 
                        Mark
        Timing of Adjuvant Chemotherapy After Surgical Resection for Non-small Cell Lung Cancer : A Target Trial Emulation Using Nationwide Swedish Registry Data
    
    - Contribution to journal › Article
 
- 
                        Mark
        Clinical Implementation of Urinary Biomarkers for Surveillance of Non-muscle-invasive Bladder Cancer (NMIBC) : Considerations from the European Association of Urology NMIBC Guideline Panel
    
    - Contribution to journal › Debate/Note/Editorial
 
